SecBot SecBot
SECBOTREPLAY Home › Report › INM

INM · InMed Pharmaceuticals filed a prospectus supplement to its shelf…

InMed Pharmaceuticals Inc. · 8-K filed Apr 3, 2026 at 16:19 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Apr 3, 2026 at 16:19 ET

InMed Pharmaceuticals filed a prospectus supplement to its shelf registration statement to sell up to $1,213,648 worth of common shares through an at-the-market offering with H.C. Wainwright & Co. This is a routine capital raise under an existing agreement.

  • InMed Pharmaceuticals filed a prospectus supplement on April 3, 2026, to sell up to $1,213,648 of common shares.
  • The offering is conducted through an at-the-market (ATM) agreement with H.C. Wainwright & Co., originally dated April 7, 2022, and amended June 27, 2024.
  • The shares are being offered under a shelf registration statement (Form S-3, File No. 333-294503) declared effective on March 30, 2026.
  • The filing includes a legal opinion confirming the legality of the securities being registered.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access